Sarepta Therapeutics Inc (LTS:0L35)
$ 121.67 0 (0%) Market Cap: 11.61 Bil Enterprise Value: 11.80 Bil PE Ratio: 78.90 PB Ratio: 9.50 GF Score: 82/100

Sarepta Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 02, 2022 / 01:00PM GMT
Release Date Price: $74.35
Operator

Good morning, and welcome to the Annual Meeting of Stockholders of Sarepta Therapeutics, Inc. Please note that today's meeting is being recorded. (Operator Instructions)

It is now my pleasure to turn today's meeting over to Dr. M. Kathleen Behrens. The floor is yours.

M. Kathleen Behrens
Sarepta Therapeutics, Inc. - Independent Chairwoman

Good morning, and welcome to the 2022 Annual Meeting of Stockholders for Sarepta Therapeutics. It is now a few minutes after 9:00 a.m. Eastern Daylight Time, and the meeting will please come to order. My name is Dr. M. Kathleen Behrens. And as Chairwoman of the Board of Directors of Sarepta, I will be presiding over this meeting. Doug Ingram, President and Chief Executive Officer of Sarepta, will also preside over a portion of the meeting. Ryan Brown, Senior Vice President, General Counsel and Corporate Secretary, will record the proceedings.

I will turn to the order of the business of today's meeting, which will follow the agenda that is attached to the document section of the webcast. If you have

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot